摘要
The central role of sequential accumulation of genetic alterations during the development of cancer has been firmly established since the pioneering cytogenetic studies successfully defined recurrent chromosome changes in spedfic types of tumor. In the course of carcinogenesis, cells experience several genetic alterations that are associated with the transition from a preneoplastic lesion to an invasive tumor and finally to the metastatic state. Tumor progression is characterized by stepwise accumulation of genetic alterations.So does the dominant metastatic clone. Modern molecular genetic analyses have clarified that genomic changes accumulate during the development and progression of cancers. In comparison with the corresponding primary tumor,additional events of chromosomal aberrations (including gains or allelic losses) are frequently found in metastases, and the incidence of combined chromosomal alterations in the primary tumor, plus the occurrence of additional aberrations inthe distant metastases, correlated significantly with decreased postmetastatic survival. The deletions at 3p, 4p, 6q, 8p, 10q,11p, 11q, 12p, 13q, 16q, 17p, 18q, 21q, and 22q, as well as the over-representations at 1q, 8q, 9q, 14q and 15q, have been found to associate preferentially with the metastatic phenotype of human cancers. Among of them, the deletions on chromosomes 8p, 17p, 11p and 13p seem to be more significant, and more detail fine regions of them, including 8p11, 8p21-12, 8p22, 8p23, 17p13.3, 11p15.5, and 13q12-13 have been suggested harboring metastasis-suppressor genes.During the past decade, several human chromosomes have been functionally tested through the use of microcell-mediated chromosome transfer (MMCT), and metastasis-suppressor activities have been reported on chromosomes 1, 6, 7, 8, 10,11, 12, 16, and 17. However, it is not actually known at what stage of the metastatic cascade these alterations have occurred.There is still controversial with the association between the chromosomal aberrations and the metastatic phenotype of cancer. As the progression of human genome project and the establishment of more and more new techniques, it is hopeful to make clear the genetic mechanisms involved in the tumor metastasis in a not very long future, and provide new clues to predicting and controlling the metastasis.
The central role of sequential accumulation of genetic alterations during the development of cancer has been firmly established since the pioneering cytogenetic studies successfully defined recurrent chromosome changes in specific types of tumor.In the course of carcinogenesis,cells experience several genetic alterations that are associated with the transition from a preneoplastic lesion to an invasive tumor and finally to the metastatic state.Tumor progression is characterized by stepwise accumulation of genetic alterations. So does the dominant metastatic clone.Modern molecular genetic analyses have clarified that genomic changes accumulate during the development and progression of cancers.In comparison with the corresponding primary tumor, additional events of chromosomal aberrations(including gains or allelic losses)are frequently found in metastases,and the incidence of combined chromosomal alterations in the primary tumor,plus the occurrence of additional aberrations in the distant metastases,correlated significantly with decreased postmetastatic survival.The deletions at 3p,4p,6q,8p,10q, 11p,11q,12p,13q,16q,17p,18q,21q,and 22q,as well as the over-representations at lq,8q,9q,14q and 15q,have been found to associate preferentially with the metastatic phenotype of human cancers.Among of them,the deletions on chromosomes 8p,17p,11p and 13p seem to be more significant,and more detail fine regions of them,including 8p11,8p21-12,8p22,8p23,17p13.3,11p15.5,and 13q12-13 have been suggested harboring metastasis-suppressor genes. During the past decade,several human chromosomes have been functionally tested through the use of microcell-mediated chromosome transfer(MMCT),and metastasis-suppressor activities have been reported on chromosomes 1,6,7,8,10, 11,12,16,and 17.However,it is not actually known at what stage of the metastatic cascade these alterations have occurred. There is still controversial with the association between the chromosomal aberrations and the metastatic phenotype of cancer.As the progression of human genome project and the establishment of more and more new techniques,it is hopeful to make clear the genetic mechanisms involved in the tumor metastasis in a not very long future,and provide new clues to predicting and controlling the metastasis.
